drugset / Trial / NCT00628667

Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux

NCT00628667

Phase 4 Completed 120 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

This study looks at how effective acid suppression therapy is on symptoms associated with chronic posterior laryngitis (CPL) in patients with documented pharyngeal acid reflux.

Timeline

Start
2002-02
Primary completion
2003-03
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg Oral

Indications